Fig. 2From: Patterns of use of symptomatic treatments for Alzheimer's disease dementia (AD)Median time to first symptomatic AD therapy in a major U.S. health plan (A) and CPRD (B) databasesM+R: Memantine + Rivastigamine; D+M: Donepezil + MemantineBack to article page